NASDAQ:ACRS
Aclaris Therapeutics Stock Insider Trading
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 35.486.
In total, the insiders bought 1 884 257 and sold 844 637 ACRS shares in the last 100 trades.
| Date | Action | Amount | Person | Type |
| Mar 17, 2023 | Buy | 6 300 | Manion Douglas J. | Common Stock |
| Mar 09, 2023 | Buy | 6 500 | Manion Douglas J. | Common Stock |
| Mar 01, 2023 | Buy | 96 150 | Walker Neal | Common Stock |
| Mar 01, 2023 | Buy | 18 275 | Walker Neal | Common Stock |
| Mar 01, 2023 | Buy | 24 000 | Walker Neal | Common Stock |
| Mar 02, 2023 | Sell | 29 000 | Walker Neal | Common Stock |
| Mar 02, 2023 | Buy | 18 254 | Walker Neal | Common Stock |
| Mar 03, 2023 | Sell | 30 240 | Walker Neal | Common Stock |
| Mar 01, 2023 | Sell | 96 150 | Walker Neal | Restricted Stock Units |
| Mar 01, 2023 | Sell | 18 275 | Walker Neal | Restricted Stock Units |
| Mar 01, 2023 | Sell | 24 000 | Walker Neal | Restricted Stock Units |
| Mar 02, 2023 | Sell | 18 254 | Walker Neal | Restricted Stock Units |
| Mar 01, 2023 | Buy | 13 750 | Monahan Joseph | Common Stock |
| Mar 01, 2023 | Buy | 50 000 | Monahan Joseph | Common Stock |
| Mar 01, 2023 | Buy | 10 925 | Monahan Joseph | Common Stock |
| Mar 02, 2023 | Sell | 14 800 | Monahan Joseph | Common Stock |
| Mar 02, 2023 | Buy | 12 500 | Monahan Joseph | Common Stock |
| Mar 03, 2023 | Sell | 16 037 | Monahan Joseph | Common Stock |
| Mar 01, 2023 | Sell | 13 750 | Monahan Joseph | Restricted Stock Units |
| Mar 01, 2023 | Sell | 50 000 | Monahan Joseph | Restricted Stock Units |
| Mar 01, 2023 | Sell | 10 925 | Monahan Joseph | Restricted Stock Units |
| Mar 02, 2023 | Sell | 12 500 | Monahan Joseph | Restricted Stock Units |
| Mar 01, 2023 | Buy | 1 475 | Balthaser Kevin | Common Stock |
| Mar 01, 2023 | Buy | 1 100 | Balthaser Kevin | Common Stock |
| Mar 01, 2023 | Buy | 2 375 | Balthaser Kevin | Common Stock |
| Mar 02, 2023 | Sell | 1 000 | Balthaser Kevin | Common Stock |
| Mar 02, 2023 | Buy | 1 500 | Balthaser Kevin | Common Stock |
| Mar 03, 2023 | Sell | 894 | Balthaser Kevin | Common Stock |
| Mar 01, 2023 | Sell | 1 475 | Balthaser Kevin | Restricted Stock Units |
| Mar 01, 2023 | Sell | 1 100 | Balthaser Kevin | Restricted Stock Units |
| Mar 01, 2023 | Sell | 2 375 | Balthaser Kevin | Restricted Stock Units |
| Mar 02, 2023 | Sell | 1 500 | Balthaser Kevin | Restricted Stock Units |
| Feb 15, 2023 | Sell | 5 000 | Monahan Joseph | Common Stock |
| Feb 08, 2023 | Sell | 4 267 | Loerop James | Common Stock |
| Feb 01, 2023 | Sell | 25 000 | Walker Neal | Common Stock |
| Feb 02, 2023 | Sell | 1 079 | Walker Neal | Common Stock |
| Feb 02, 2023 | Sell | 600 | Walker Neal | Common Stock |
| Feb 02, 2023 | Sell | 3 121 | Walker Neal | Common Stock |
| Feb 02, 2023 | Sell | 200 | Walker Neal | Common Stock |
| Feb 01, 2023 | Buy | 105 000 | Monahan Joseph | Employee Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 30 000 | Monahan Joseph | Restricted Stock Units |
| Feb 01, 2023 | Buy | 378 000 | Manion Douglas J. | Employee Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 108 000 | Manion Douglas J. | Restricted Stock Units |
| Feb 01, 2023 | Buy | 11 250 | Loerop James | Common Stock |
| Feb 01, 2023 | Buy | 105 000 | Loerop James | Employee Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 30 000 | Loerop James | Restricted Stock Units |
| Feb 01, 2023 | Sell | 11 250 | Loerop James | Restricted Stock Units |
| Feb 01, 2023 | Buy | 105 000 | Cawkwell Gail | Employee Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 30 000 | Cawkwell Gail | Restricted Stock Units |
| Feb 01, 2023 | Buy | 105 000 | Balthaser Kevin | Employee Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 30 000 | Balthaser Kevin | Restricted Stock Units |
| Nov 08, 2022 | Sell | 4 000 | Powell Andrew Kenneth William | Common Stock |
| Jan 01, 2023 | Sell | 0 | Balthaser Kevin | Common Stock |
| Jan 01, 2023 | Sell | 9 500 | Balthaser Kevin | Restricted Stock Units |
| Jan 03, 2023 | Sell | 23 382 | Walker Neal | Common Stock |
| Jan 03, 2023 | Sell | 1 618 | Walker Neal | Common Stock |
| Jan 04, 2023 | Sell | 15 000 | Walker Neal | Common Stock |
| Dec 15, 2022 | Sell | 5 000 | Monahan Joseph | Common Stock |
| Nov 10, 2022 | Sell | 11 395 | Schiff Andrew N | Common Stock |
| Nov 11, 2022 | Sell | 41 160 | Schiff Andrew N | Common Stock |
| Nov 14, 2022 | Sell | 1 371 | Schiff Andrew N | Common Stock |
| Oct 24, 2022 | Sell | 14 616 | Schiff Andrew N | Common Stock |
| Oct 25, 2022 | Sell | 12 018 | Schiff Andrew N | Common Stock |
| Oct 26, 2022 | Sell | 14 540 | Schiff Andrew N | Common Stock |
| Oct 17, 2022 | Sell | 19 944 | Schiff Andrew N | Common Stock |
| Oct 18, 2022 | Sell | 32 093 | Schiff Andrew N | Common Stock |
| Oct 17, 2022 | Sell | 5 000 | Monahan Joseph | Common Stock |
| Oct 07, 2022 | Sell | 7 324 | Schiff Andrew N | Common Stock |
| Oct 06, 2022 | Sell | 37 839 | Schiff Andrew N | Common Stock |
| Oct 04, 2022 | Sell | 7 700 | Schiff Andrew N | Common Stock |
| Aug 01, 2022 | Buy | 217 800 | Manion Douglas J. | Employee Stock Option (Right to Buy) |
| Aug 01, 2022 | Buy | 0 | Manion Douglas J. | |
| Jul 01, 2022 | Buy | 210 000 | Cawkwell Gail | Employee Stock Option (Right to Buy) |
| Jun 27, 2022 | Buy | 0 | Cawkwell Gail | |
| Jun 17, 2022 | Sell | 19 565 | Schiff Andrew N | Common Stock |
| Jun 02, 2022 | Sell | 3 356 | Schiff Andrew N | Restricted Stock Units |
| Jun 02, 2022 | Buy | 4 507 | Schiff Andrew N | Restricted Stock Units |
| Jun 02, 2022 | Buy | 15 750 | Reasons Bryan M. | Stock Option (Right to Buy) |
| Jun 02, 2022 | Sell | 3 356 | Reasons Bryan M. | Restricted Stock Units |
| Jun 02, 2022 | Sell | 3 356 | Powell Andrew Kenneth William | Restricted Stock Units |
| Jun 02, 2022 | Sell | 709 | Powell Andrew Kenneth William | Common Stock |
| Jun 02, 2022 | Buy | 4 507 | Powell Andrew Kenneth William | Restricted Stock Units |
| Jun 02, 2022 | Buy | 15 750 | Molineaux Christopher P. | Stock Option (Right to Buy) |
| Jun 02, 2022 | Buy | 3 356 | Molineaux Christopher P. | Common Stock |
| Jun 02, 2022 | Buy | 3 356 | Milano Vincent | Common Stock |
| Jun 02, 2022 | Buy | 4 507 | Milano Vincent | Restricted Stock Units |
| Jun 02, 2022 | Sell | 3 356 | Mehra Anand | Restricted Stock Units |
| Jun 02, 2022 | Buy | 4 507 | Mehra Anand | Restricted Stock Units |
| Jun 02, 2022 | Buy | 3 356 | Humphries William D. | Common Stock |
| Jun 02, 2022 | Buy | 15 750 | Humphries William D. | Stock Option (Right to Buy) |
| Jun 02, 2022 | Sell | 3 356 | Gowen Maxine | Restricted Stock Units |
| Jun 02, 2022 | Buy | 4 507 | Gowen Maxine | Restricted Stock Units |
| Apr 21, 2022 | Sell | 25 000 | Walker Neal | Common Stock |
| Apr 18, 2022 | Sell | 30 000 | Monahan Joseph | Common Stock |
| Mar 11, 2022 | Sell | 56 303 | Walker Neal | Common Stock |
| Mar 10, 2022 | Sell | 12 823 | Ruffo Frank | Common Stock |
| Mar 10, 2022 | Sell | 27 165 | Monahan Joseph | Common Stock |
| Mar 01, 2022 | Buy | 13 750 | Monahan Joseph | Common Stock |
| Mar 01, 2022 | Buy | 50 000 | Monahan Joseph | Common Stock |
| Mar 02, 2022 | Buy | 12 500 | Monahan Joseph | Common Stock |
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
